Takeda Pharmaceutical (TAK) Earnings Date, Estimates & Call Transcripts

$18.71 +0.28 (+1.52%)

As of 09/3/2026 03:58 PM Eastern

Takeda Pharmaceutical Earnings Summary

Takeda Pharmaceutical posted Q1 2027 earnings on July 30, 2026, reporting an EPS of $0.95, which beat the consensus estimate of $0.41 by $0.54. Quarterly revenue was reported to be $7.50 billion, above analysts' expectations of $7.13 billion. With a trailing EPS of $0.34 and a P/E Ratio of 55.03, Takeda Pharmaceutical's earnings are expected to decrease -15.58% next year, from $1.54 to $1.30 per share.

Upcoming Q2 Earnings Date: Oct. 29Before Market OpensEstimated
Consensus EPS (Jul. 30): $0.41
Actual EPS (Jul. 30): $0.95 Beat By $0.54
Actual Revenue (Jul. 30): $7.50B

Q1 2027 Earnings Resources

TAK Upcoming Earnings

Takeda Pharmaceutical's next earnings date is estimated for Thursday, October 29, 2026, based on past reporting schedules.

Slide Deck

Full Screen Slide Deck

Get Takeda Pharmaceutical Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Takeda Pharmaceutical and other key companies, straight to your inbox.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

TAK Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

TAK Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Takeda Pharmaceutical Analyst EPS Estimates

Current Year EPS Consensus Estimate: $1.54 EPS
Next Year EPS Consensus Estimate: $1.30 EPS

Takeda Pharmaceutical Earnings History by Quarter

Time Frame

Start Date

End Date

Export

Date	Quarter	Consensus Estimate	Reported EPS	Beat/Miss	GAAP EPS	Revenue Estimate	Actual Revenue	Details
10/29/2026 (Estimated)	-	-	-	-	-	-	-	-
7/30/2026	Q1 2027	$0.41	$0.95	+$0.54	$0.22	$7.13B	$7.50B
3/31/2026	Q4 2025	-	$0.5610	-	-$0.0483	-	$6.90B
1/30/2026	Q3 2026	$0.55	$0.48	-$0.07	$0.21	$7.81B	$7.60B
10/30/2025	Q2 2026	$0.44	$0.44	-	-$0.03	$8.01B	$7.30B
7/30/2025	Q1 2026	$0.47	$0.52	+$0.05	$0.27	$7.96B	$7.45B
5/8/2025	Q4 2025	$0.24	$0.16	-$0.08	-$0.21	$8.02B	$7.34B
1/30/2025	Q3 2025	$0.34	$0.42	+$0.08	$0.05	-	-

Takeda Pharmaceutical Earnings - Frequently Asked Questions

Takeda Pharmaceutical has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, October 29th, 2026 based off last year's report dates. Learn more on TAK's earnings history.

Takeda Pharmaceutical updated its FY 2026 earnings guidance on Thursday, July, 30th. The company provided earnings per share guidance of 3.009-3.009 for the period, compared to the consensus earnings per share estimate of 1.570. The company issued revenue guidance of $29.6 billion-$29.6 billion, compared to the consensus revenue estimate of $29.0 billion.

In the previous quarter, Takeda Pharmaceutical (NYSE:TAK) reported $0.95 earnings per share (EPS) to beat the analysts' consensus estimate of $0.41 by $0.54. Learn more on analysts' earnings estimate vs. TAK's actual earnings.

The conference call for Takeda Pharmaceutical's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Takeda Pharmaceutical's latest earnings report can be read online.
Read Transcript

Takeda Pharmaceutical (NYSE:TAK) has a recorded annual revenue of $28.32 billion.

Takeda Pharmaceutical (NYSE:TAK) has a recorded net income of -$1.01 billion. TAK has generated $0.34 earnings per share over the last four quarters.

Takeda Pharmaceutical (NYSE:TAK) has a trailing price-to-earnings ratio of 55.03 and a forward price-to-earnings ratio of 12.15.

Takeda Pharmaceutical's earnings are expected to decrease from $1.54 per share to $1.30 per share in the next year, which is a -15.58% change.

More Earnings Resources from MarketBeat

Related Companies

Earnings Tools

Latest Articles

Earnings data for NYSE:TAK is sourced from Fiscal.ai, with the most recent quarter reported on 7/30/2026. New results are added as companies report their earnings.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Takeda Pharmaceutical (TAK) Earnings Date, Estimates & Call Transcripts